E-merge Capital Partners

E Merge Capital Partners

Capital Markets, 2210 Faraday Ave, Solana Beach, California, 92075, United States, 1-10 Employees

e-mergecapital.com

  • LinkedIn

phone no Phone Number: +12*********

Who is E-MERGE CAPITAL PARTNERS

E-merge Capital Partners is a venture capital and growth equity firm dedicated to investing in innovative, early-stage medical device companies and technologies to improve quality of life...

Read More

map
  • 2210 Faraday Ave, Solana Beach, California, 92075, United States Headquarters: 2210 Faraday Ave, Solana Beach, California, 92075, United States
  • 2021 Date Founded: 2021
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Capital Markets

SIC SIC Code: 3841 | NAICS Code: 334510 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from E-MERGE CAPITAL PARTNERS

E-merge Capital Partners Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding E-merge Capital Partners

Answer: E-merge Capital Partners's headquarters are located at 2210 Faraday Ave, Solana Beach, California, 92075, United States

Answer: E-merge Capital Partners's phone number is +12*********

Answer: E-merge Capital Partners's official website is https://e-mergecapital.com

Answer: E-merge Capital Partners's revenue is Under $1 Million

Answer: E-merge Capital Partners's SIC: 3841

Answer: E-merge Capital Partners's NAICS: 334510

Answer: E-merge Capital Partners has 1-10 employees

Answer: E-merge Capital Partners is in Capital Markets

Answer: E-merge Capital Partners contact info: Phone number: +12********* Website: https://e-mergecapital.com

Answer: E-merge Capital Partners is a venture capital and growth equity firm dedicated to investing in innovative, early-stage medical device companies and technologies to improve quality of life. We focus our resources on what we have identified as underserved markets and utilize proven de-risking criteria to maximize successful exits. E-merge Fund I is focused primarily on class II medical devices in the cardiovascular and orthopedic markets but will consider investing in other regulatory classes and medical specialties where technologies meet the firms stringent de-risking criteria. E-merge assumes an active role in the operations and management of its portfolio companies by way of its partnership with Evolve Medtech Venture Studio. We work in tandem with inventors and physicians to provide disciplined development and design to medical device technologies. In conjunction with our hands-on approach to innovation, we identify premarket submission pathways that provide for the quickest possible exit times for our LPs.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access